SMT set to take “highly deliverable” stent across Europe, India this month
Supraflex Cruz is a Sirolimus eluting stent built on a Cobalt Chromium Platform
Indian stent-maker SMT or Sahajanand Medical Technologies has said it
was ready to make its new and “highly deliverable” version of the
Supraflex drug-eluting stent commercially available in Europe from
Thursday.
This development comes after the Supraflex Cruz received the approval (CE mark) from the European regulatory recently . In fact, a little less than a year ago, a study in Europe found that the Supraflex stent system could be compared to Abbott’s Xience stent.
The stent only involved a change in design, making it more deliverable and thus “substantially” reducing procedure time for doctors and patients, the researcher told.
Supraflex Cruz is a Sirolimus eluting stent built on a Cobalt Chromium Platform and has been implanted in more than 2,50,000 patients in select Indian centres and certain international markets over the last three years. “The drug and polymer have not been changed,” he said. The company is also looking to increase the availability of the new product in India as well.
Stents are wire-like products used to unclog arteries. Deploying a stent can be difficult if the arteries are highly calcified or present in a location that was too deep, he said, adding that companies were constantly innovating on design to make their stents easily deliverable.
The new product would find acceptance in Europe, he explained, because of an elderly population who may have more complicated arteries and who would not be able to spend too much time in an operation theater.
This development comes after the Supraflex Cruz received the approval (CE mark) from the European regulatory recently . In fact, a little less than a year ago, a study in Europe found that the Supraflex stent system could be compared to Abbott’s Xience stent.
The stent only involved a change in design, making it more deliverable and thus “substantially” reducing procedure time for doctors and patients, the researcher told.
Supraflex Cruz is a Sirolimus eluting stent built on a Cobalt Chromium Platform and has been implanted in more than 2,50,000 patients in select Indian centres and certain international markets over the last three years. “The drug and polymer have not been changed,” he said. The company is also looking to increase the availability of the new product in India as well.
Stents are wire-like products used to unclog arteries. Deploying a stent can be difficult if the arteries are highly calcified or present in a location that was too deep, he said, adding that companies were constantly innovating on design to make their stents easily deliverable.
The new product would find acceptance in Europe, he explained, because of an elderly population who may have more complicated arteries and who would not be able to spend too much time in an operation theater.
THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE
HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.
PS-
THOSE INTERESTED IN
RECIPES ARE FREE TO VIEW MY BLOG-
https://gseasyrecipes.blogspot.com/
FOR INFO ABOUT KNEE
REPLACEMENT, YOU CAN VIEW MY BLOG-
https:// kneereplacement-stickclub.blogspot.com/
FOR
CROCHET DESIGNS
https://gscrochetdesigns.blogspot.com
Labels: cobale chromium platform, more deliverable, reducing procedure, sirolimus eluting stent, stent, substantially
0 Comments:
Post a Comment
<< Home